How to Buy Supernus Pharmaceuticals Stock
Supernus Pharmaceuticals Inc
Supernus Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
Supernus Pharmaceuticals stock last closed at $30.07, up 2.59% from the previous day, and has decreased 18.18% in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.11 percentage points. Supernus Pharmaceuticals stock is currently +36.74% from its 52-week low of $21.99, and -21.06% from its 52-week high of $38.09.
At the moment, there are 54.73M SUPN shares outstanding. The market cap of SUPN is $1.65B. In the past 24 hours, 330,640 SUPN shares were traded.
How to Buy Supernus Pharmaceuticals Stock
Wondering how to invest in Supernus Pharmaceuticals stock? Here's how.
- Choose where to buy Supernus Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Supernus Pharmaceuticals stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Select your payment method and add your details.
- Analyze Supernus Pharmaceuticals stock: The Supernus Pharmaceuticals ticker symbol is SUPN. Is Supernus Pharmaceuticals stock a good investment? Should you buy shares of SUPN? How do SUPN's underlying business fundamentals look? Do top analysts think Supernus Pharmaceuticals is a good buy? Why has SUPN's stock price moved recently? (Hint: Our stock market research website can help you decide if SUPN is a good stock to buy).
- Place your SUPN purchase: Decide if you will purchase SUPN shares at the current market price or use a limit order to buy SUPN shares at a specific price.
- Keep tabs on your investment in SUPN: Create a watchlist to important notifications about your new investment in Supernus Pharmaceuticals shares.
Step 1: Choose where to buy Supernus Pharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy SUPN stock.
Our favorite brokerage: eToro
In our opinion, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Real Estate, New York to Hong Kong — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro today.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked your brokerage, it's time to fill out some personal info so you are able to buy SUPN stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to start a new brokerage account.
- Submit your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have created your account on the best stock app for beginners, you need to deposit funds:
Check out the tutorial below to see the process of transferring money into your brokerage account.
Step 4: Analyze Supernus Pharmaceuticals stock
After you have chosen the best place to buy Supernus Pharmaceuticals stock, it's important to evaluate their stock prior to buying, so you actually comprehend the risk and opportunity.
Supernus Pharmaceuticals shares at a glance
SUPN Due Diligence Checks
WallStreetZen was designed to help part-time investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on SUPN's stock page.
Is SUPN stock undervalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge SUPN's true value.
Using relative valuations measures:
- SUPN may be overvalued based on its P/E ratio of 1,503.5x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 33.92x
- SUPN may be undervalued based on its P/B ratio of 1.79x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.09x
- SUPN may be overvalued based on its PEG ratio of 3.26x
You can do more valuation research on SUPN's stock here.
SUPN Financial Health
Positive Health Checks:
- SUPN has a low debt to equity ratio of 0.39.
- There are more short-term assets than short-term liabilities on the SUPN balance sheet.
- There are more short-term assets than long-term liabilities on the SUPN balance sheet.
- Total SUPN debt is lower than 5 years ago, relative to shareholder equity.
- SUPN's operating cash flow of $111.09M allows it to safely service it's debt of $33.20M.
Negative Health Checks:
- SUPN profit margin has gone down from 9.1% to 0.2% in the past year.
- SUPN earnings of $5.18M is not sufficient to cover its interest payments.
Is it a good time to buy Supernus Pharmaceuticals stock, according to analysts?
Out of 1 sell side analysts who give recommendations on SUPN, the consensus analyst rating on Supernus Pharmaceuticals is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Supernus Pharmaceuticals stock forecast page.
Metrics for Advanced SUPN Traders
How is SUPN performing as a company?
Last year, SUPN earnings were $1.32M. Over the last 5 year, SUPN's earnings have gone up by -60.69% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of -9.47%.
Last year, SUPN revenue was $607.52M. In the last five year, SUPN's revenue has grown by 8.24% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 30.65%.
Dive into SUPN's earnings and revenue performance here.
What are SUPN insiders up to?
In the last 12 months, executives and large shareholders at SUPN have sold more shares than they have bought.
Padmanabh P. Bhatt, Sr. VP of IP CSO of SUPN, was the latest SUPN insider to sell. They sold $511,677.21 worth of SUPN shares on Mar 21, 2024.
Research more about who owns SUPN shares here.
Does SUPN stock generate passive income?
No, Supernus Pharmaceuticals doesn't provide an income stream by paying out dividends.
SUPN Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your SUPN purchase
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a given dollar amount limit, place a limit order.
Hit the Open button and eToro will execute the order.
If you need more help buying stocks on eToro, watch the how to video below:
Step 6: Keep tabs on your investment in SUPN
Now that you own some shares in SUPN, you'll want to stay up-to-date on your shares.
Make a watchlist to get the latest updates about your SUPN stock.
SUPN Feed
How to Buy Stock in Supernus Pharmaceuticals
To summarize, here are the 6 steps for buying Supernus Pharmaceuticals stock:
- Choose where to buy Supernus Pharmaceuticals stock
- Create your brokerage account
- Deposit funds into your brokerage account
- Analyze Supernus Pharmaceuticals stock
- Place your SUPN purchase
- Keep tabs on your investment in SUPN
If you need a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Supernus Pharmaceuticals, create a watchlist on WallStreetZen today.
Other Stock Buying Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.